Jim Cramer on Baxter: “They Are the King of Disappointment”

Group 1 - Baxter International Inc. is perceived as a significant disappointment in the market, with a notable recommendation to consider alternatives like Abbott Labs [1] - The company provides a range of medical devices, pharmaceuticals, and digital health technologies, including IV solutions and surgical products [2] - Concerns have been raised regarding Baxter's capital allocation decisions, management changes, and sensitivity to hospital budgets, leading to a shift in investment focus towards Linde [2] Group 2 - Despite its defensive characteristics, Baxter is viewed as less favorable compared to certain AI stocks that present greater upside potential and lower downside risk [2]